{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:18:04Z","timestamp":1793452684848,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1038\/s41440-023-01323-w","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T08:29:33Z","timestamp":1685694573000},"page":"1900-1907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Preeclampsia up to date\u2014What\u2019s going on?"],"prefix":"10.1038","volume":"46","author":[{"given":"Kanako","family":"Bokuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"1323_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377:613\u201322.","journal-title":"N Engl J Med"},{"key":"1323_CR2","doi-asserted-by":"publisher","first-page":"650.e1","DOI":"10.1016\/j.ajog.2019.09.041","volume":"221","author":"P Chaemsaithong","year":"2019","unstructured":"Chaemsaithong P, Pooh RK, Zheng M, Ma R, Chaiyasit N, Tokunaka M, et al. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. Am J Obstet Gynecol. 2019;221:650.e1\u2013650.e16.","journal-title":"Am J Obstet Gynecol"},{"key":"1323_CR3","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","volume":"214","author":"N O\u2019Gorman","year":"2016","unstructured":"O\u2019Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks gestation. Am J Obstet Gynecol. 2016;214:103.e1\u2013103.e12.","journal-title":"Am J Obstet Gynecol"},{"key":"1323_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41440-020-00558-1","volume":"44","author":"C Yue","year":"2021","unstructured":"Yue C, Gao J, Zhang C, Ni Y, Ying C. Development and validation of a nomogram for the early prediction of preeclampsia in pregnant Chinese women. Hypertens Res. 2021;44:417\u201325.","journal-title":"Hypertens Res"},{"key":"1323_CR5","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","volume":"393","author":"KE Duhig","year":"2019","unstructured":"Duhig KE, Myers J, Seed PT, Sparkes J, Lowe J, Hunter RM, et al. Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial. Lancet. 2019;393:1807\u201318.","journal-title":"Lancet"},{"key":"1323_CR6","doi-asserted-by":"publisher","first-page":"58.e1","DOI":"10.1016\/j.ajog.2011.07.037","volume":"206","author":"S Verlohren","year":"2012","unstructured":"Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, et al. The sFlt-1\/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol. 2012;206:58.e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"1323_CR7","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/HYPERTENSIONAHA.117.09256","volume":"69","author":"S Verlohren","year":"2017","unstructured":"Verlohren S, Perschel FH, Thilaganathan B, Dr\u00f6ge LA, Henrich W, Busjahn A, et al. Angiogenic markers and cardiovascular indices in the prediction of hypertensive disorders of pregnancy. Hypertension. 2017;69:1192\u20137.","journal-title":"Hypertension"},{"key":"1323_CR8","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJMoa055352","volume":"355","author":"RJ Levine","year":"2006","unstructured":"Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992\u20131005.","journal-title":"N Engl J Med"},{"key":"1323_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, Lim K-H, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 2004;350:672\u201383.","journal-title":"N Engl J Med"},{"key":"1323_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.119.12739","volume":"74","author":"AS Cerdeira","year":"2019","unstructured":"Cerdeira AS, O\u2019Sullivan J, Ohuma EO, Harrington D, Szafranski P, Black R, et al. Randomized interventional study on prediction of preeclampsia\/eclampsia in women with suspected preeclampsia: INSPIRE. Hypertension. 2019;74:983\u201390.","journal-title":"Hypertension"},{"key":"1323_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/uog.19178","volume":"53","author":"H Zeisler","year":"2019","unstructured":"Zeisler H, Llurba E, Chantraine FJ, Vatish M, Staff AC, Sennstr\u00f6m M, et al. Soluble fms-like tyrosine kinase-1 to placental growth factor ratio: ruling out pre-eclampsia for up to 4 weeks and value of retesting. Ultrasound Obstet Gynecol J Int Soc Ultrasound Obstet Gynecol. 2019;53:367\u201375.","journal-title":"Ultrasound Obstet Gynecol J Int Soc Ultrasound Obstet Gynecol"},{"key":"1323_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-14-324","volume":"14","author":"M Hund","year":"2014","unstructured":"Hund M, Allegranza D, Schoedl M, Dilba P, Verhagen-Kamerbeek W, Stepan H. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth. 2014;14:324.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1323_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstr\u00f6m M, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13\u201322.","journal-title":"N Engl J Med"},{"key":"1323_CR14","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41440-021-00624-2","volume":"44","author":"A Ohkuchi","year":"2021","unstructured":"Ohkuchi A, Masuyama H, Yamamoto T, Kikuchi T, Taguchi N, Wolf C, et al. Economic evaluation of the sFlt-1\/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study. Hypertens Res J Jpn Soc Hypertens. 2021;44:822\u20139.","journal-title":"Hypertens Res J Jpn Soc Hypertens"},{"key":"1323_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41371-021-00488-6","volume":"36","author":"Y Chen","year":"2022","unstructured":"Chen Y, Wang X, Hu W, Chen Y, Ning W, Lu S, et al. A risk model that combines MAP, PlGF, and PAPP-A in the first trimester of pregnancy to predict hypertensive disorders of pregnancy. J Hum Hypertens. 2022;36:184\u201391.","journal-title":"J Hum Hypertens"},{"key":"1323_CR16","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s41440-021-00650-0","volume":"44","author":"L Liu","year":"2021","unstructured":"Liu L, Li H, Wang N, Song X, Zhao K, Zhang C. Assessment of plasma cell-free DNA and ST2 as parameters in gestational hypertension and preeclampsia. Hypertens Res. 2021;44:996\u20131001.","journal-title":"Hypertens Res"},{"key":"1323_CR17","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00011-012-0507-x","volume":"61","author":"P Zhou","year":"2012","unstructured":"Zhou P, Luo X, Qi H-B, Zong W-J, Zhang H, Liu D-D, et al. The expression of pentraxin 3 and tumor necrosis factor-alpha is increased in preeclamptic placental tissue and maternal serum. Inflamm Res. 2012;61:1005\u201312.","journal-title":"Inflamm Res"},{"key":"1323_CR18","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41440-020-0434-0","volume":"43","author":"CC Colmenares-Mej\u00eda","year":"2020","unstructured":"Colmenares-Mej\u00eda CC, Quintero-Lesmes DC, Bautista-Ni\u00f1o PK, Guio Mahecha E, Beltr\u00e1n Avenda\u00f1o M, D\u00edaz Mart\u00ednez LA, et al. Pentraxin-3 is a candidate biomarker on the spectrum of severity from pre-eclampsia to HELLP syndrome: GenPE study. Hypertens Res. 2020;43:884\u201391.","journal-title":"Hypertens Res"},{"key":"1323_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2019.07.007","volume":"94","author":"Y Araki","year":"2020","unstructured":"Araki Y, Yanagida M. Hypertensive disorders of pregnancy: strategy to develop clinical peptide biomarkers for more accurate evaluation of the pathophysiological status of this syndrome. Adv Clin Chem. 2020;94:1\u201330.","journal-title":"Adv Clin Chem"},{"key":"1323_CR20","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1038\/s41440-021-00747-6","volume":"44","author":"I Wakabayashi","year":"2021","unstructured":"Wakabayashi I, Yanagida M, Araki Y. Associations of cardiovascular risk with circulating peptides related to hypertensive disorders of pregnancy. Hypertens Res. 2021;44:1641\u201351.","journal-title":"Hypertens Res"},{"key":"1323_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14390\/jsshp.10.57","volume":"10","author":"K Takagi","year":"2022","unstructured":"Takagi K, Nakamoto O, Watanabe K, Tanaka K, Matsubara K, Kawabata I, et al. A review of best practice guide 2021 for diagnosis and management of hypertensive disorders of pregnancy (HDP) - misc. - researchmap. Hypertens Res Pregnancy. 2022;10:57\u201373.","journal-title":"Hypertens Res Pregnancy"},{"key":"1323_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","volume":"72","author":"MA Brown","year":"2018","unstructured":"Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. 2018;72:24\u201343.","journal-title":"Hypertension"},{"key":"1323_CR23","doi-asserted-by":"crossref","unstructured":"Espinoza J, Vidaeff A, Pettker CM, Simhan H. ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy. Obstet Gynecol. 2018;132:e44\u2013e52.","DOI":"10.1097\/AOG.0000000000002708"},{"key":"1323_CR24","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1001\/jama.2021.8551","volume":"326","author":"JT Henderson","year":"2021","unstructured":"Henderson JT, Vesco KK, Senger CA, Thomas RG, Redmond N. Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;326:1192\u2013206.","journal-title":"JAMA"},{"key":"1323_CR25","doi-asserted-by":"publisher","first-page":"S1196","DOI":"10.1016\/j.ajog.2020.07.026","volume":"226","author":"LA Magee","year":"2022","unstructured":"Magee LA, Khalil A, Kametas N, von Dadelszen P. Toward personalized management of chronic hypertension in pregnancy. Am J Obstet Gynecol. 2022;226:S1196\u2013210.","journal-title":"Am J Obstet Gynecol"},{"key":"1323_CR26","doi-asserted-by":"publisher","first-page":"1021548","DOI":"10.3389\/fphar.2022.1021548","volume":"13","author":"A Hirsch","year":"2022","unstructured":"Hirsch A, Rotem R, Ternovsky N, Hirsh Raccah B. Pravastatin and placental insufficiency associated disorders: a systematic review and meta-analysis. Front Pharm. 2022;13:1021548.","journal-title":"Front Pharm"},{"key":"1323_CR27","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.121.053963","volume":"144","author":"M D\u00f6bert","year":"2021","unstructured":"D\u00f6bert M, Varouxaki AN, Mu AC, Syngelaki A, Ciobanu A, Akolekar R, et al. Pravastatin versus placebo in pregnancies at high risk of term preeclampsia. Circulation. 2021;144:670\u20139.","journal-title":"Circulation"},{"key":"1323_CR28","doi-asserted-by":"crossref","unstructured":"Espinoza J, Vidaeff A, Pettker CM, Simhan H. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135:e237\u2013e260.","DOI":"10.1097\/AOG.0000000000003891"},{"key":"1323_CR29","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","volume":"133","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics.","year":"2019","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics. ACOG Practice Bulletin No. 203: chronic hypertension in pregnancy. Obstet Gynecol. 2019;133:e26\u2013e50.","journal-title":"Obstet Gynecol"},{"key":"1323_CR30","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s41440-022-00965-6","volume":"45","author":"H Metoki","year":"2022","unstructured":"Metoki H, Iwama N, Hamada H, Satoh M, Murakami T, Ishikuro M, et al. Hypertensive disorders of pregnancy: definition, management, and out-of-office blood pressure measurement. Hypertens Res. 2022;45:1298\u2013309.","journal-title":"Hypertens Res"},{"key":"1323_CR31","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"1323_CR32","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1161\/HYPERTENSIONAHA.120.14875","volume":"76","author":"CJ Nobles","year":"2020","unstructured":"Nobles CJ, Mendola P, Mumford SL, Silver RM, Kim K, Andriessen VC, et al. Preconception blood pressure and its change into early pregnancy: early risk factors for preeclampsia and gestational. Hypertension. 2020;76:922\u20139.","journal-title":"Hypertension"},{"key":"1323_CR33","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/s41440-020-0438-9","volume":"43","author":"N Li","year":"2020","unstructured":"Li N, An H, Li Z, Ye R, Zhang L, Li H, et al. Preconception blood pressure and risk of gestational hypertension and preeclampsia: a large cohort study in China. Hypertens Res. 2020;43:956\u201362.","journal-title":"Hypertens Res"},{"key":"1323_CR34","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/jch.14149","volume":"23","author":"J Huai","year":"2021","unstructured":"Huai J, Lin L, Juan J, Chen J, Li B, Zhu Y, et al. Preventive effect of aspirin on preeclampsia in high\u2010risk pregnant women with stage 1 hypertension. J Clin Hypertens. 2021;23:1060\u20137.","journal-title":"J Clin Hypertens"},{"key":"1323_CR35","doi-asserted-by":"crossref","unstructured":"Slade LJ, Mistry HD, Bone JN, Wilson M, Blackman M, Syeda N, et al. American College of Cardiology and American Heart Association blood pressure categories\u2014a systematic review of the relationship with adverse pregnancy outcomes in the first half of pregnancy. Am J Obstet Gynecol. 2023;228:418\u201329.e34.","DOI":"10.1016\/j.ajog.2022.10.004"},{"key":"1323_CR36","doi-asserted-by":"crossref","unstructured":"Suzuki H, Takagi K, Matsubara K, Mito A, Kawasaki K, Nanjo S, et al. Maternal and perinatal outcomes according to blood pressure levels for prehypertension: a review and meta-analysis. Hypertens Res Pregnancy. 2022;10:29\u201339.","DOI":"10.14390\/jsshp.HRP2021-018"},{"key":"1323_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41440-021-00763-6","volume":"45","author":"A Ueda","year":"2022","unstructured":"Ueda A, Hasegawa M, Matsumura N, Sato H, Kosaka K, Abiko K, et al. Lower systolic blood pressure levels in early pregnancy are associated with a decreased risk of early-onset superimposed preeclampsia in women with chronic hypertension: a multicenter retrospective study. Hypertens Res. 2022;45:135\u201345.","journal-title":"Hypertens Res"},{"key":"1323_CR38","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1097\/AOG.0000000000002019","volume":"129","author":"Committee on Obstetric Practice.","year":"2017","unstructured":"Committee on Obstetric Practice. Committee Opinion No. 692: emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol. 2017;129:e90\u20135.","journal-title":"Obstet Gynecol"},{"key":"1323_CR39","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S0140-6736(19)31282-6","volume":"394","author":"T Easterling","year":"2019","unstructured":"Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, et al. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial. Lancet. 2019;394:1011\u201321.","journal-title":"Lancet"},{"key":"1323_CR40","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/HYPERTENSIONAHA.121.18415","volume":"79","author":"JN Bone","year":"2022","unstructured":"Bone JN, Sandhu A, Abalos ED, Khalil A, Singer J, Prasad S, et al. Oral antihypertensives for nonsevere pregnancy hypertension: systematic review, network meta- and trial sequential analyses. Hypertension. 2022;79:614\u201328.","journal-title":"Hypertension"},{"key":"1323_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41440-019-0387-3","volume":"43","author":"Q Huang","year":"2020","unstructured":"Huang Q, Hu B, Han X, Yang J, Di X, Bao J, et al. Cyclosporin A ameliorates eclampsia seizure through reducing systemic inflammation in an eclampsia-like rat model. Hypertens Res. 2020;43:263\u201370.","journal-title":"Hypertens Res"},{"key":"1323_CR42","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41440-020-00609-7","volume":"44","author":"X Chen","year":"2021","unstructured":"Chen X, Huang J, Lv Y, Chen Y, Rao J. Crocin exhibits an antihypertensive effect in a rat model of gestational hypertension and activates the Nrf-2\/HO-1 signaling pathway. Hypertens Res. 2021;44:642\u201350.","journal-title":"Hypertens Res"},{"key":"1323_CR43","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0140-6736(19)31963-4","volume":"394","author":"LC Chappell","year":"2019","unstructured":"Chappell LC, Brocklehurst P, Green ME, Hunter R, Hardy P, Juszczak E, et al. Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial. Lancet. 2019;394:1181\u201390.","journal-title":"Lancet"},{"key":"1323_CR44","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/HYPERTENSIONAHA.118.11191","volume":"73","author":"B Thilaganathan","year":"2019","unstructured":"Thilaganathan B, Kalafat E. Cardiovascular system in preeclampsia and beyond. Hypertension. 2019;73:522\u201331.","journal-title":"Hypertension"},{"key":"1323_CR45","first-page":"19","volume":"3","author":"T Vakhtangadze","year":"2019","unstructured":"Vakhtangadze T, Gakhokidze N, Khutsishvili M, Mosidze S. The link between hypertension and preeclampsia\/eclampsia-life-long cardiovascular risk for women. Vessel. 2019;3:19.","journal-title":"Vessel"},{"key":"1323_CR46","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/bmj.39335.385301.BE","volume":"335","author":"L Bellamy","year":"2007","unstructured":"Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.","journal-title":"BMJ"},{"key":"1323_CR47","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/CIRCULATIONAHA.117.031403","volume":"137","author":"MB Minissian","year":"2018","unstructured":"Minissian MB, Kilpatrick S, Eastwood J-A, Robbins WA, Accortt EE, Wei J, et al. Association of spontaneous preterm delivery and future maternal cardiovascular disease. Circulation. 2018;137:865\u201371.","journal-title":"Circulation"},{"key":"1323_CR48","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCULATIONAHA.118.038080","volume":"140","author":"LJ Leon","year":"2019","unstructured":"Leon LJ, McCarthy FP, Direk K, Gonzalez-Izquierdo A, Prieto-Merino D, Casas JP, et al. Preeclampsia and cardiovascular disease in a large UK pregnancy cohort of linked electronic health records. Circulation. 2019;140:1050\u201360.","journal-title":"Circulation"},{"key":"1323_CR49","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1016\/j.jacc.2019.09.052","volume":"74","author":"MC Honigberg","year":"2019","unstructured":"Honigberg MC, Zekavat SM, Aragam K, Klarin D, Bhatt DL, Scott NS, et al. Long-term cardiovascular risk in women with hypertension during pregnancy. J Am Coll Cardiol. 2019;74:2743\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"1323_CR50","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41440-020-0463-8","volume":"43","author":"M Wagata","year":"2020","unstructured":"Wagata M, Kogure M, Nakaya N, Tsuchiya N, Nakamura T, Hirata T, et al. Hypertensive disorders of pregnancy, obesity, and hypertension in later life by age group: a cross-sectional analysis. Hypertens Res. 2020;43:1277\u201383.","journal-title":"Hypertens Res"},{"key":"1323_CR51","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1016\/j.jacc.2018.11.004","volume":"73","author":"PWF Wilson","year":"2019","unstructured":"Wilson PWF, Polonsky TS, Miedema MD, Khera A, Kosinski AS, Kuvin JT. Systematic review for the 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73:3210\u201327.","journal-title":"J Am Coll Cardiol"},{"key":"1323_CR52","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","volume":"74","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74:1376\u2013414.","journal-title":"J Am Coll Cardiol"},{"key":"1323_CR53","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1097\/AOG.0000000000003243","volume":"133","author":"American College of Obstetricians and Gynecologists\u2019 Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins\u2014Obstetrics.","year":"2019","unstructured":"American College of Obstetricians and Gynecologists\u2019 Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins\u2014Obstetrics. ACOG Practice Bulletin No. 212: pregnancy and heart disease. Obstet Gynecol. 2019;133:e320\u201356.","journal-title":"Obstet Gynecol"},{"key":"1323_CR54","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1161\/01.STR.0000206284.96739.ee","volume":"37","author":"DW Brown","year":"2006","unstructured":"Brown DW, Dueker N, Jamieson DJ, Cole JW, Wozniak MA, Stern BJ, et al. Preeclampsia and the risk of ischemic stroke among young women. Stroke. 2006;37:1055\u20139.","journal-title":"Stroke"},{"key":"1323_CR55","doi-asserted-by":"crossref","unstructured":"Poulter NR, Chang CL, Farley TMM, Meirik O, Marmot MG. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre, case-control study. Lancet. 1996;348:505\u201310.","DOI":"10.1016\/S0140-6736(95)12394-6"},{"key":"1323_CR56","doi-asserted-by":"crossref","unstructured":"World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contarception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet. 1995;346:1575\u201382.","DOI":"10.1016\/S0140-6736(95)91926-0"},{"key":"1323_CR57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.preghy.2022.10.008","volume":"30","author":"AA Samara","year":"2022","unstructured":"Samara AA, Liampas I, Dadouli K, Siokas V, Zintzaras E, Stefanidis I, et al. Preeclampsia, gestational hypertension and incident dementia: a systematic review and meta-analysis of published evidence. Pregnancy Hypertens. 2022;30:192\u20137.","journal-title":"Pregnancy Hypertens"},{"key":"1323_CR58","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1161\/01.HYP.0000256565.20983.d4","volume":"49","author":"CA Hubel","year":"2007","unstructured":"Hubel CA, Wallukat G, Wolf M, Herse F, Rajakumar A, Roberts JM, et al. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension. 2007;49:612\u20137.","journal-title":"Hypertension"},{"key":"1323_CR59","doi-asserted-by":"publisher","first-page":"154.e1","DOI":"10.1016\/j.ajog.2019.03.024","volume":"221","author":"EF Zwertbroek","year":"2019","unstructured":"Zwertbroek EF, Franssen MTM, Broekhuijsen K, Langenveld J, Bremer H, Ganzevoort W, et al. Neonatal developmental and behavioral outcomes of immediate delivery versus expectant monitoring in mild hypertensive disorders of pregnancy: 2-year outcomes of the HYPITAT-II trial. Am J Obstet Gynecol. 2019;221:154.e1\u2013154.e11.","journal-title":"Am J Obstet Gynecol"},{"key":"1323_CR60","doi-asserted-by":"publisher","first-page":"l2381","DOI":"10.1136\/bmj.l2381","volume":"366","author":"GJ Burton","year":"2019","unstructured":"Burton GJ, Redman CW, Roberts JM, Moffett A. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381.","journal-title":"BMJ"},{"key":"1323_CR61","doi-asserted-by":"publisher","first-page":"e1552","DOI":"10.1542\/peds.2011-3093","volume":"129","author":"EF Davis","year":"2012","unstructured":"Davis EF, Lazdam M, Lewandowski AJ, Worton SA, Kelly B, Kenworthy Y, et al. Cardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic review. Pediatrics. 2012;129:e1552\u201361.","journal-title":"Pediatrics"},{"key":"1323_CR62","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/hy02t2.102904","volume":"39","author":"RL Davisson","year":"2002","unstructured":"Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, et al. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension. 2002;39:337\u201342.","journal-title":"Hypertension"},{"key":"1323_CR63","doi-asserted-by":"crossref","unstructured":"Allotey J, Fernandez S, Bonet M, Stallings E, Yap M, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020;370:m3320.","DOI":"10.1136\/bmj.m3320"},{"key":"1323_CR64","doi-asserted-by":"publisher","first-page":"403.e1","DOI":"10.1016\/j.ajog.2021.09.024","volume":"226","author":"E Kalafat","year":"2022","unstructured":"Kalafat E, Prasad S, Birol P, Tekin AB, Kunt A, Di Fabrizio C, et al. An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women. Am J Obstet Gynecol. 2022;226:403.e1\u2013403.e13.","journal-title":"Am J Obstet Gynecol"},{"key":"1323_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17436-6","volume":"11","author":"AJ Vivanti","year":"2020","unstructured":"Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun. 2020;11:3572.","journal-title":"Nat Commun"},{"key":"1323_CR66","doi-asserted-by":"publisher","first-page":"E540","DOI":"10.1503\/cmaj.202604","volume":"193","author":"SQ Wei","year":"2021","unstructured":"Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. Can Med Assoc J. 2021;193:E540\u2013E548.","journal-title":"Can Med Assoc J"},{"key":"1323_CR67","doi-asserted-by":"publisher","first-page":"289.e1","DOI":"10.1016\/j.ajog.2021.05.014","volume":"225","author":"AT Papageorghiou","year":"2021","unstructured":"Papageorghiou AT, Deruelle P, Gunier RB, Rauch S, Garc\u00eda-May PK, Mhatre M, et al. Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study. Am J Obstet Gynecol. 2021;225:289.e1\u2013289.e17.","journal-title":"Am J Obstet Gynecol"},{"key":"1323_CR68","doi-asserted-by":"publisher","first-page":"e759","DOI":"10.1016\/S2214-109X(21)00079-6","volume":"9","author":"B Chmielewska","year":"2021","unstructured":"Chmielewska B, Barratt I, Townsend R, Kalafat E, van der Meulen J, Gurol-Urganci I, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health. 2021;9:e759\u2013e772.","journal-title":"Lancet Glob Health"},{"key":"1323_CR69","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/1471-0528.16339","volume":"127","author":"M Mendoza","year":"2020","unstructured":"Mendoza M, Garcia-Ruiz I, Maiz N, Rodo C, Garcia-Manau P, Serrano B, et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG Int J Obstet Gynaecol. 2020;127:1374\u201380.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"1323_CR70","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00018-020-03611-x","volume":"78","author":"J Wu","year":"2021","unstructured":"Wu J, Deng W, Li S, Yang X. Advances in research on ACE2 as a receptor for 2019-nCoV. Cell Mol Life Sci CMLS. 2021;78:531\u201344.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"1323_CR71","doi-asserted-by":"publisher","first-page":"E188","DOI":"10.1002\/ajh.25882","volume":"95","author":"V Giardini","year":"2020","unstructured":"Giardini V, Carrer A, Casati M, Contro E, Vergani P, Gambacorti-Passerini C. Increased sFLT-1\/PlGF ratio in COVID-19: a novel link to angiotensin II-mediated endothelial dysfunction. Am J Hematol. 2020;95:E188\u201391.","journal-title":"Am J Hematol"},{"key":"1323_CR72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.preghy.2021.12.001","volume":"27","author":"CM Soldavini","year":"2022","unstructured":"Soldavini CM, Di Martino D, Sabattini E, Ornaghi S, Sterpi V, Erra R, et al. sFlt-1\/PlGF ratio in hypertensive disorders of pregnancy in patients affected by COVID-19. Pregnancy Hypertens. 2022;27:103\u20139.","journal-title":"Pregnancy Hypertens"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01323-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01323-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01323-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T16:34:58Z","timestamp":1744216498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01323-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1038\/s41440-023-01323-w","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"assertion":[{"value":"20 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}